AI
AMGEN INC
AMGN· Health Care· BiotechnologyS&P 500
Close · 12/10/2026
417.57
1D
+0.65%52-week range
288 – 447.03
Volume
17,20,000.00
Price history
AMGN
11/09/2026 to 12/10/2026
O 416.12 H 417.76 L 413.44
1W+3.62%
1M+10.66%
3M+17.54%
6M+19.37%
1Y+41.34%
3Y+57.53%
5Y+97.49%
MAX+83.23%
Fundamentals
as of 12/10/2026- Market cap
- $225.75B
- Shares out
- 540.63M
- P/E (trailing)
- 25.82
- P/E (forward)
- 16.94
- EPS (trailing)
- 16.17
- Dividend yield
- 2.38%
- Beta
- 0.41
- Profit margin
- 22.95%
- P/B
- 19.31
- Return on equity
- 74.80%
SEC financial statements
67 quarterly and 19 annual periods through 30/06/2026.
Details
- Ticker
- AMGN
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 12/10/2026.
Tracked by Congress
23 filers · 2 on watchlist · 37 buys · 28 sells · ?: 2 · D: 27 · R: 36
- 22/09/2026David J. TaylorBuyAmgen Inc. - Common Stock$1,001–$15,000
- 26/08/2026David J. TaylorSellAmgen Inc. - Common Stock$1,001–$15,000
- 26/08/2026David J. TaylorSellAmgen Inc. - Common Stock$1,001–$15,000
- 12/08/2026Sheldon WhitehouseSell+Amgen Inc. - Common Stock$1,001–$15,000
- 15/04/2025Thomas H TubervilleWSellAmgen Inc$15,001–$50,000
- 27/03/2026Alan ArmstrongSellAmgen Inc. - Common Stock$15,001–$50,000
- 05/06/2026David J. TaylorBuyAmgen Inc. - Common Stock$1,001–$15,000
- 17/04/2026Maria Elvira SalazarSellAmgen Inc. - Common Stock$15,001–$50,000